zolpidem

(redirected from Edluar)
Also found in: Medical.

zol·pi·dem

 (zōl′pə-dĕm′)
n.
A non-benzodiazepine sleep-inducing drug, C19H21N3O, used in its tartrate form to treat insomnia.

[(a)zol(e) + p(yrim)id(ine) + alteration of am(ide).]

zolpidem

(ˈzɒlpɪˌdɛm)
n
a drug used to treat insomnia
Translations

zolpidem

n zolpidem m
Mentioned in ?
References in periodicals archive ?
These behaviors appear to be more common with Lunesta, Sonata, Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist than other prescription medicines used for sleep.
Blast-exposure status, Marine Corps service, an infantry MOS, PTSD diagnosis, unprotected noise exposure, TCS use, hyperacusis/noise sensitivity, and zolpidem (eg, Edluar, Zolpimist, Intermezzo, Ambien) use were each significantly associated with tinnitus in the bivariate analysis.
To examine zolpidem in detail, a new focused query was performed: [(zolpidem OR ambien OR edluar) AND (seizure OR seizures) AND (case reports[PT] OR (english abstract[PT] AND case[TIAB]))].
* Food and Drug Administration (FDA), FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien C R, Edluar, and Zolpimist), Rockville, MD: FDA, 2013.
In 2005, 6,000 emergency-room cases nationwide involved Ambien and other medications containing the hypnotic drug zolpidem--such as Ambien CR, Edluar and Zolpimist.
A Zolpidem (generic), sold also under brand names Ambien, Ambien CR (extended release), Edluar (sublingual, which means under the tongue), and Zolpimist (oral spray), has been found to cause next-morning impairment for activities that require patients to be alert, including driving.
Food and Drug Administration has announced new, lower dosing requirements for certain sleep drugs that contain zolpidem, including Ambien, Ambien CR, Edluar, and ZolpiMist.
Food and Drug Administration announced new, lower dosing requirements for certain sleep drugs that contain zolpidem, including Ambien, Ambien CR, Edluar, and ZolpilAist.
M2 EQUITYBITES-June 15, 2012-MEDAa[euro](tm)s Edluar approved in Europe(C)2012 M2 COMMUNICATIONS http://www.m2.com
25 July 2011 - Swedish pharmaceutical company Orexo AB (STO: ORX) said today its insomnia drug Sublinox, known as Edluar in the USA, had been granted marketing approval in Canada.